{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T10:40:30Z","timestamp":1773916830373,"version":"3.50.1"},"reference-count":10,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2026.1822888","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T05:23:53Z","timestamp":1773897833000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Editorial: Exploring innovative therapies for rare inflammatory skin diseases"],"prefix":"10.3389","volume":"13","author":[{"given":"Dennis","family":"Niebel","sequence":"first","affiliation":[{"name":"Department of Dermatology, University Medical Center Regensburg","place":["Regensburg, Germany"]},{"name":"Heinz-Werner-Seifert-Institut f\u00fcr Dermatopathologie K\u00f6lnBonn","place":["Bonn, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u0161ko","family":"Mi\u0161e","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, University Hospital Center Zagreb","place":["Zagreb, Croatia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joerg","family":"Wenzel","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital Bonn","place":["Bonn, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"B1","unstructured":"Kyowa Kirin\n              US\n            \n          \n          Kyowa Kirin Announces Discontinuation of Rocatinlimab Clinical Trials\n          \n          2026"},{"key":"B2","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.det.2024.02.006","article-title":"The psoriasis treatment pipeline: an overview and update","volume":"42","author":"Hawkes","year":"2024","journal-title":"Dermatol Clin."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1111\/all.16009","article-title":"Treatment of atopic dermatitis: recently approved drugs and advanced clinical development programs","volume":"79","author":"M\u00fcller","year":"2024","journal-title":"Allergy."},{"key":"B4","doi-asserted-by":"publisher","first-page":"7729","DOI":"10.1038\/s41467-022-35319-w","article-title":"Spatial transcriptomics landscape of lesions from non-communicable inflammatory skin diseases","volume":"13","author":"Sch\u00e4bitz","year":"2022","journal-title":"Nat Commun."},{"key":"B5","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/jdv.14673","article-title":"Immune response patterns in non-communicable inflammatory skin diseases","volume":"32","author":"Eyerich","year":"2018","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.jid.2021.08.439","article-title":"Targeted therapies in autoimmune skin diseases","volume":"142","author":"Braegelmann","year":"2022","journal-title":"J Invest Dermatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"10688","DOI":"10.1038\/s41467-024-54559-6","article-title":"Immune modules to guide diagnosis and personalized treatment of inflammatory skin diseases","volume":"15","author":"Seremet","year":"2024","journal-title":"Nat Commun."},{"key":"B8","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/jdv.70251","article-title":"Dermatology 20: precision medicine for inflammatory skin diseases","volume":"40","author":"Di Domizio","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1056\/NEJMc1412997","article-title":"Remission of recalcitrant dermatomyositis treated with ruxolitinib","volume":"371","author":"Hornung","year":"2014","journal-title":"N Engl J Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"adv00144","DOI":"10.2340\/00015555-3481","article-title":"Unexpected hair regrowth in a patient with longstanding alopecia universalis during treatment of recalcitrant dermatomyositis with the janus kinase inhibitor ruxolitinib","volume":"100","author":"Fetter","year":"2020","journal-title":"Acta Derm Venereol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1822888\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T05:23:55Z","timestamp":1773897835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1822888\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":10,"alternative-id":["10.3389\/fmed.2026.1822888"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1822888","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"article-number":"1822888"}}